EGFR and Alzheimer disease: For instance, an investigation of miR-146a regulation of EGFR in AD may tie this miRNA to a proliferative pathway; logically, if these molecules are negatively regulated and miR-146a is up-regulated in AD, one would expect a decrease in EGFR, with possible subsequent neurodegenerative effects.